PTGX

Protagonist Therapeutics, Inc.

A biotechnology company that designs oral and injectable peptide drugs for chronic conditions like psoriasis, blood disorders, and obesity. Founded in 2006 on peptide technology from the University of Pennsylvania, it was incubated in Australia before moving to California. Its name was chosen to suggest a central role in peptide medicine, and its psoriasis pill Icotyde is licensed to Johnson & Johnson.

Recent Activity

Show $

2026Q2

1 buy1 sell

Bridgewater Associates LPADD

+4.0K shares(+75.7%)

Bridgewater Associates LPADD

+4.0K shares(+75.7%)

Polen Capital ManagementTRIM

-1.7K shares(-6.9%)

Polen Capital ManagementTRIM

-1.7K shares(-6.9%)

2026Q1

2 buys

Bridgewater Associates LPNEW

+5.3K shares

Bridgewater Associates LPNEW

+5.3K shares

Polen Capital ManagementADD

+4.0K shares(+19.6%)

Polen Capital ManagementADD

+4.0K shares(+19.6%)

Loading more activity...